• 1. Extraction of dl-anabasine from Alangium platanifolium root using an emulsion liquid membrane
  Zhifeng Guo,Huidan Su,Ru Cai,Xiaoli Ma Anal. Methods 2015 7 1860
• 2. Biosynthesis of anabasine in transformed root cultures of Nicotiana species
  Allan B. Watson,Alison M. Brown,Ian J. Colquhoun,Nicholas J. Walton,David J. Robins J. Chem. Soc. Perkin Trans. 1 1990 2607
• 3. Protonating and determining myosmine intactly by association with citrate anion
  Bo Chen,Qingping Xu Analyst 2011 136 4846
• 4. Synthesis of anabasine-6′-carboxylic acid from aldosine, the aldol crosslinking amino acid of elastin
  Fumihiko Nakamura,Kyozo Suyama J. Chem. Soc. Perkin Trans. 1 1993 1007
• 5. A review of the analysis of biomarkers of exposure to tobacco and vaping products
  Arezoo Habibagahi,Nicholas Alderman,Cariton Kubwabo Anal. Methods 2020 12 4276

• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Alkaloids and derivatives
• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives
• Natural Products and Extracts Plant Extracts Plant based Liparia vestita
• Natural Products and Extracts Plant Extracts Plant based Crenidium spinescens
• Natural Products and Extracts Plant Extracts Plant based Anthocercis ilicifolia
• Natural Products and Extracts Plant Extracts Plant based Anthocercis genistoides

Professional Introduction to 3-(Piperidin-2-yl)pyridine (CAS No. 13078-04-1)

3-(Piperidin-2-yl)pyridine, identified by its Chemical Abstracts Service (CAS) number 13078-04-1, is a significant compound in the field of pharmaceutical chemistry and medicinal biology. This heterocyclic amine derivative has garnered considerable attention due to its versatile structural framework and potential applications in drug development. The compound’s unique combination of a piperidine ring and a pyridine moiety makes it a valuable scaffold for designing molecules with enhanced pharmacological properties.

The< strong>piperidine moiety, characterized by its six-membered nitrogen-containing ring, is well-known for its role in stabilizing bioactive molecules and improving metabolic stability. In contrast, the< strong>pyridine ring contributes to lipophilicity and binding affinity, making it a common feature in many successful drugs. The synergistic effect of these two structural components in 3-(piperidin-2-yl)pyridine has led to its exploration in various therapeutic areas.

Recent advancements in medicinal chemistry have highlighted the importance of 3-(piperidin-2-yl)pyridine as a key intermediate in the synthesis of small-molecule inhibitors. For instance, studies have demonstrated its utility in developing kinase inhibitors, which are crucial for treating cancers and inflammatory diseases. The compound’s ability to modulate protein-protein interactions has also been leveraged in the design of drugs targeting neurological disorders.

In the realm of drug discovery, 3-(piperidin-2-yl)pyridine has been employed as a building block for more complex molecules. Its structural flexibility allows for modifications that can fine-tune pharmacokinetic and pharmacodynamic profiles. Researchers have utilized computational methods to predict how different substituents on the piperidine and pyridine rings can influence binding affinity and selectivity. These insights have guided the optimization of lead compounds towards higher efficacy and reduced side effects.

The compound’s relevance extends to the development of antiviral agents as well. Emerging research suggests that derivatives of 3-(piperidin-2-yl)pyridine may interfere with viral replication by inhibiting key enzymes or disrupting protein-protein interactions within viral particles. Such findings are particularly pertinent in the context of rapidly evolving pathogens that pose significant challenges to global health.

In addition to its pharmaceutical applications, 3-(piperidin-2-yl)pyridine has shown promise in materials science. Its ability to form stable complexes with metal ions has been explored for applications in catalysis and sensor technology. The compound’s chelating properties make it an attractive candidate for designing metal-organic frameworks (MOFs) with tailored functionalities.

The synthesis of 3-(piperidin-2-yl)pyridine typically involves multi-step organic reactions, often starting from readily available precursors such as piperidine and pyridine derivatives. Advances in synthetic methodologies have improved the efficiency and scalability of these processes, making it more feasible to produce larger quantities for research and industrial purposes. Catalytic techniques have also been refined to enhance yields while minimizing byproduct formation.

Ongoing research continues to uncover new applications for 3-(piperidin-2-yl)pyridine. Collaborative efforts between academia and industry are driving innovation in drug discovery pipelines, leveraging this compound’s unique properties. As computational chemistry tools become more sophisticated, virtual screening approaches are being used to identify novel derivatives with enhanced therapeutic potential.

The future prospects for 3-(piperidin-2-yl)pyridine are promising, with potential applications emerging in areas such as precision medicine and personalized therapeutics. Its role as a versatile scaffold suggests that it will remain a cornerstone of pharmaceutical innovation for years to come. As our understanding of biological systems grows, so too will the opportunities to harness this compound’s full potential.

• 494-52-0(Anabasine)
• 66148-18-3((±)-Nornicotine-d)
• 350818-69-8(rac-Nicotine-d4)
• 130342-99-3(2-(Pyridin-3-yl)azepane)
• 18793-19-6(Pyridine,3-[(2R,4S)-2-(3-pyridinyl)-4-piperidinyl]-, rel-)
• 5746-86-1((±)-Nornicotine)
• 69980-24-1(rac-Nicotine-d3)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)